These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33893164)

  • 1. Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT).
    Beernink JM; Oosterwijk MM; Khunti K; Gupta P; Patel P; van Boven JFM; Lambers Heerspink HJ; Bakker SJL; Navis G; Nijboer RM; Laverman GD
    Diabetes Care; 2021 Jun; 44(6):1419-1425. PubMed ID: 33893164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT).
    Beernink JM; Oosterwijk MM; van Boven JFM; Heerspink HJL; Bakker SJL; Navis G; Nijboer RM; Gant CM; Haverkate H; Kruik-Kollöffel WJ; Laverman GD
    Front Pharmacol; 2022; 13():888110. PubMed ID: 35903346
    [No Abstract]   [Full Text] [Related]  

  • 3. Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors.
    Gant CM; Binnenmars SH; Harmelink M; Soedamah-Muthu SS; Bakker SJL; Navis G; Laverman GD
    Nutr Diabetes; 2018 Apr; 8(1):24. PubMed ID: 29695715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes.
    Patel P; Gupta P; Burns A; Suwaidan AA; Cole R; Lane D; Seidu S; Khunti K
    Diabetes Care; 2019 Jun; 42(6):1132-1135. PubMed ID: 30885952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
    Calip GS; Elmore JG; Boudreau DM
    Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
    An J; Nichol MB
    Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Highly Tailored Text and Voice Messaging Intervention to Improve Medication Adherence in Patients With Either or Both Hypertension and Type 2 Diabetes in a UK Primary Care Setting: Feasibility Randomized Controlled Trial of Clinical Effectiveness.
    Kassavou A; Mirzaei V; Brimicombe J; Edwards S; Massou E; Prevost AT; Griffin S; Sutton S
    J Med Internet Res; 2020 May; 22(5):e16629. PubMed ID: 32427113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.
    Oñatibia-Astibia A; Malet-Larrea A; Larrañaga B; Gastelurrutia MÁ; Calvo B; Ramírez D; Cantero I; Garay Á; Goyenechea E
    Health Serv Res; 2019 Jun; 54(3):658-668. PubMed ID: 30957240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.
    Balkhi B; Alwhaibi M; Alqahtani N; Alhawassi T; Alshammari TM; Mahmoud M; Almetwazi M; Ata S; Kamal KM
    BMJ Open; 2019 Jul; 9(7):e029280. PubMed ID: 31340969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
    Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial.
    Huang Z; Tan E; Lum E; Sloot P; Boehm BO; Car J
    JMIR Mhealth Uhealth; 2019 Sep; 7(9):e14914. PubMed ID: 31516127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).
    Yokoyama H; Oishi M; Takamura H; Yamasaki K; Shirabe SI; Uchida D; Sugimoto H; Kurihara Y; Araki SI; Maegawa H
    BMJ Open Diabetes Res Care; 2016; 4(1):e000294. PubMed ID: 27752329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.
    Simpson SH; Lin M; Eurich DT
    Ann Pharmacother; 2016 Sep; 50(9):741-6. PubMed ID: 27307411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients.
    de Vries FM; Voorham J; Hak E; Denig P
    Curr Med Res Opin; 2015 Dec; 31(12):2197-206. PubMed ID: 26359331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
    Johnson L; Rayner B
    Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.
    Balkrishnan R; Rajagopalan R; Camacho FT; Huston SA; Murray FT; Anderson RT
    Clin Ther; 2003 Nov; 25(11):2958-71. PubMed ID: 14693318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.